BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31746851)

  • 1. Thermoresponsive drug delivery to mitochondria in vivo.
    Ruan L; Zhou M; Chen J; Huang H; Zhang J; Sun H; Chai Z; Hu Y
    Chem Commun (Camb); 2019 Dec; 55(97):14645-14648. PubMed ID: 31746851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thermoresponsive nanocarrier for mitochondria-targeted drug delivery.
    Wang D; Huang H; Zhou M; Lu H; Chen J; Chang YT; Gao J; Chai Z; Hu Y
    Chem Commun (Camb); 2019 Apr; 55(28):4051-4054. PubMed ID: 30870553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro/vivo evaluation of novel mitochondrial targeting charge-reversal polysaccharide-based antitumor nanoparticle.
    Fang L; Lin H; Wu Z; Wang Z; Fan X; Cheng Z; Hou X; Chen D
    Carbohydr Polym; 2020 Apr; 234():115930. PubMed ID: 32070547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitochondria-targeted thiazoleorange-based photothermal agent for enhanced photothermal therapy for tumors.
    Bian W; Pan Z; Wang Y; Long W; Chen Z; Chen N; Zeng Y; Yuan J; Liu X; Lu YJ; He Y; Zhang K
    Bioorg Chem; 2021 Aug; 113():104954. PubMed ID: 34023651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP
    Song H; Xing W; Shi X; Zhang T; Lou H; Fan P
    Bioorg Med Chem; 2021 Nov; 50():116466. PubMed ID: 34700239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sp
    Kallepu S; Neeli PK; Mallappa S; Nagendla NK; Reddy Mudiam MK; Mainkar PS; Kotamraju S; Chandrasekhar S
    ChemMedChem; 2020 Oct; 15(19):1826-1833. PubMed ID: 32893968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica-encapsulated gold nanoparticle dimers for organelle-targeted cellular delivery.
    Cong VT; Ly NH; Son SJ; Min J; Joo SW
    Chem Commun (Camb); 2017 May; 53(36):5009-5012. PubMed ID: 28426043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Intracellular Ca
    Xu L; Tong G; Song Q; Zhu C; Zhang H; Shi J; Zhang Z
    ACS Nano; 2018 Jul; 12(7):6806-6818. PubMed ID: 29966081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted combinational therapy inducing mitochondrial dysfunction.
    Shin WS; Park SK; Verwilst P; Koo S; Lee JH; Chi SG; Kim JS
    Chem Commun (Camb); 2017 Jan; 53(7):1281-1284. PubMed ID: 28067351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.
    Morrison DE; Aitken JB; de Jonge MD; Ioppolo JA; Harris HH; Rendina LM
    Chem Commun (Camb); 2014 Mar; 50(18):2252-4. PubMed ID: 24352097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage.
    Zhu M; Li Y; Zhou Z
    Biochem Biophys Res Commun; 2017 Oct; 492(3):373-378. PubMed ID: 28847725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-melanin colloidal nanospheres: an efficient near-infrared photothermal therapeutic agent for in vivo cancer therapy.
    Liu Y; Ai K; Liu J; Deng M; He Y; Lu L
    Adv Mater; 2013 Mar; 25(9):1353-9. PubMed ID: 23280690
    [No Abstract]   [Full Text] [Related]  

  • 14. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
    Zielonka J; Joseph J; Sikora A; Hardy M; Ouari O; Vasquez-Vivar J; Cheng G; Lopez M; Kalyanaraman B
    Chem Rev; 2017 Aug; 117(15):10043-10120. PubMed ID: 28654243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-targeted drug delivery in cancers.
    Cho H; Cho YY; Shim MS; Lee JY; Lee HS; Kang HC
    Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165808. PubMed ID: 32333953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold nanorods with a noncovalently tailorable surface for multi-modality image-guided chemo-photothermal cancer therapy.
    Yue L; Sun C; Cheng Q; Ding Y; Wei J; Wang R
    Chem Commun (Camb); 2019 Nov; 55(90):13506-13509. PubMed ID: 31626260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance.
    Li Y; Xu X; Zhang X; Li Y; Zhang Z; Gu Z
    ACS Nano; 2017 Jan; 11(1):416-429. PubMed ID: 28005335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of drugs and macromolecules to the mitochondria for cancer therapy.
    Lu P; Bruno BJ; Rabenau M; Lim CS
    J Control Release; 2016 Oct; 240():38-51. PubMed ID: 26482081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes for drug delivery to mitochondria.
    Boddapati SV; D'Souza GG; Weissig V
    Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.